Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target decreased by equities researchers at Wells Fargo & Company from $25.00 to $24.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has an "overweight" rating on the stock. Wells Fargo & Company's price objective points to a potential upside of 25.64% from the company's current price.
Several other brokerages also recently commented on BBWI. JPMorgan Chase & Co. lifted their target price on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a "neutral" rating in a report on Tuesday, August 18th. Argus restated a "hold" rating on shares of Bath & Body Works in a research report on Wednesday, September 16th. BMO Capital Markets assumed coverage on Bath & Body Works in a report on Tuesday, September 8th. They set a "market perform" rating and a $20.00 price objective for the company. Deutsche Bank set a $22.00 target price on Bath & Body Works in a research report on Thursday, August 27th. Finally, Barclays lowered their target price on Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 27th. Three research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $22.33.
Get Our Latest Analysis on Bath & Body Works
Bath & Body Works Price Performance
BBWI stock traded up $0.19 during midday trading on Friday, reaching $19.10. 1,006,437 shares of the company were exchanged, compared to its average volume of 6,018,714. Bath & Body Works has a one year low of $14.27 and a one year high of $24.94. The firm has a market capitalization of $3.85 billion, a price-to-earnings ratio of 4.98, a price-to-earnings-growth ratio of 0.93 and a beta of 1.31. The business has a 50-day moving average price of $19.24 and a two-hundred day moving average price of $19.77.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, November 19th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.14. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company's revenue was down 1.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.37 earnings per share. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, analysts anticipate that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Bath & Body Works
Several institutional investors and hedge funds have recently modified their holdings of the business. Allworth Financial LP increased its position in Bath & Body Works by 3.1% during the third quarter. Allworth Financial LP now owns 17,371 shares of the company's stock worth $277,000 after acquiring an additional 521 shares during the period. Pathstone Holdings LLC raised its stake in Bath & Body Works by 1.1% in the 3rd quarter. Pathstone Holdings LLC now owns 52,031 shares of the company's stock worth $828,000 after purchasing an additional 581 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Bath & Body Works by 35.5% in the 1st quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock valued at $48,000 after purchasing an additional 673 shares during the period. Rothschild Investment LLC boosted its holdings in Bath & Body Works by 12.5% in the 3rd quarter. Rothschild Investment LLC now owns 7,570 shares of the company's stock valued at $121,000 after purchasing an additional 841 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Bath & Body Works by 40.7% in the 2nd quarter. GAMMA Investing LLC now owns 5,050 shares of the company's stock valued at $117,000 after purchasing an additional 1,460 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Top Bath & Body Works Stories
Investors following BBWI have been watching these stories:
- Positive Sentiment: Third-quarter adjusted earnings of $0.26 per share topped the $0.12 consensus, and revenue of $1.58 billion also exceeded expectations. The company raised its full-year sales outlook, citing progress in digital and wholesale channels, although revenue was down year over year. Third-quarter results and outlook
- Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a seasonal product and marketing partnership, though its financial impact is not yet clear. Pantone holiday collection announcement
- Negative Sentiment: The fourth-quarter adjusted EPS outlook of $1.41–$1.61 is below the $1.72 analyst consensus, with sales guidance also at or below expectations. This cautious holiday forecast appears to temper the positive earnings surprise; full-year adjusted EPS guidance remains $2.60–$2.80. Fiscal 2026 outlook coverage
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.